Recent publications
Article
Peck-Radosavljevic, M, Abdelgafur, A, Granito, A, Gasbarrini, A, Ma, YT, Mena, E, Lledó-Navarro, JL, Presa, J, Weinmann, A, Levy, MT, Pellicelli, A, Waldschmidt, DT, Sørensen, HT, Goyal, L, Ren, M, Saal, H, Okpara, CE & Meyer, T 2026, 'An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final Analysis', Liver Cancer. https://doi.org/10.1159/000552115
O'Rourke, JM, Kavanagh, D, O'Keeffe, A, Savoye, K, Yang, K, Patten, DA, Willoughby, CE, Llovet, JM, Neag, G, Reeves, HL, Hewett, PW, Kalia, N, Shah, T, Ma, YT, Hunter, K, Flint, J, McMurray, JL, Cain, O, Spill, F, Mann, DA, Naylor, AJ, Heath, V, Weston, CJ, Bicknell, R & Shetty, S 2026, 'CLEC14A correlates with neutrophil infiltration in hepatocellular carcinoma and mediates neutrophil recruitment across liver endothelial cells', Journal of Pathology. https://doi.org/10.1002/path.70077
Pancreatic Cancer Neoadjuvant Therapy Audit Collaborative, Alarabiyat, M, Rehman, S, Labib, PL, Powell-Brett, S, Hall, L, Edwards, D, Ma, YT, Sivakumar, S, Good, J, Raza, SS, Dasari, B, Marudanayagam, R, Bartlett, D, Roberts, KJ, Sutcliffe, R, Pathanki, A, Jahnsen, H, Suthananthan, A, Fong, C, Teng, MJ, Kaur, J, Candish, C, Elyan, S, Nagy, A, Baburaj, B, Bose, S, Khaja, MS, Tsalic, M, Hafeez, T, Joseph, M, Rashid, M, Kunene, V, Chatterjee, A, Tween, H, Asghar, S, Ferreira, A, Johnson, K, McDonald, C, Williams, A, Weir, K, Jones, G, Boyle, S, toby Mullett, M, Hart, R, Riddell, M, King, S, Bullock, C, Jones, L & Chatzizacharias, N 2026, 'Intention to treat outcomes following management of locally advanced pancreatic ductal adenocarcinoma with curative intent: single centre cohort study', HPB, vol. 28, no. 9, pp. 1250-1264. https://doi.org/10.1016/j.hpb.2026.06.008
Kudo, M, Vogel, A, Evans, TRJ, Ma, YT, Daniele, B, Baron, AD, Mahipal, A, Qin, S, Blanc, J-F, Lopez, CL, Cheng, A-L, Choo, SP, Piscaglia, F, Mody, K, Ren, M & Chan, SL 2026, 'Lenvatinib versus Sorafenib in First-Line Treatment of Older Patients with Unresectable Hepatocellular Carcinoma: A Subgroup Analysis of the REFLECT Trial', Liver Cancer. https://doi.org/10.1159/000553375
Yuan-Doré, JSJ, Rashid, M, Ueshima, K, Lopes, A, Ma, YT, Ross, P, Palmer, D, Kudo, M & Meyer, T 2026, 'Pattern of progression and post-progression survival following transarterial embolisation: An analysis of the TACE-2 and TACTICS trials', JHEP Reports, vol. 8, no. 5, 101791. https://doi.org/10.1016/j.jhepr.2026.101791
Advanced Biliary Cancer (ABC) Working Group 2026, 'Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin–5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial', ESMO Open, vol. 11, no. 7, 107777. https://doi.org/10.1016/j.esmoop.2026.107777
Clarke, G, Dhanaraj, S, Hull, D, Panton, M, Mergental, H, Afford, SC, Shetty, S, Karkhanis, S, Mehrzad, H, Ma, YT, Punia, P, Shah, T & Dasari, BVM 2026, 'Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma', Scientific Reports, vol. 16, 8014. https://doi.org/10.1038/s41598-025-23968-y
Vrana, E, Timmins, H, Osborne, A, Cox, R, Wasan, H, Ma, YT, Arora, A, Faluyi, O, Gillmore, R, Corrie, P, Miller, P, Arif, S, Canham, J, Martin, C, Riaz, M, Shi, T, Frizziero, M, Foy, V, Hubner, RA, Morement, H, Bridgewater, J, Adams, R, Valle, JW & McNamara, MG 2025, 'ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabine', Future Oncology, vol. 21, no. 21, pp. 2713-2721. https://doi.org/10.1080/14796694.2025.2539018
Ma, YT, Zuo, J, Kirkham, A, Curbishley, S, Blahova, M, Rowe, AL, Bathurst, C, Mehrzad, H, Karkhanis, S, Punia, P, James, MW, Stern, N, Rao, A, Hull, D, Lowe, F, Sylla, P, Webster, L, Hussain, S, Yap, C, Palmer, D & Adams, DH 2025, 'Addition of Dendritic Cell Vaccination to Conditioning Cyclophosphamide and Chemoembolization in Patients with Hepatocellular Carcinoma: The ImmunoTACE Trial', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 31, no. 16, pp. 3412-3423. https://doi.org/10.1158/1078-0432.CCR-25-0142
Palmer, DH, Jackson, R, Springfeld, C, Ghaneh, P, Rawcliffe, C, Halloran, CM, Faluyi, O, Cunningham, D, Wadsley, J, Darby, S, Meyer, T, Gillmore, R, Lind, P, Glimelius, B, Falk, S, Ma, YT, Middleton, GW, Cummins, S, Ross, PJ, Wasan, H, McDonald, A, Crosby, T, Hammel, P, Borg, D, Sothi, S, Valle, JW, Mehrabi, A, Bailey, P, Tjaden, C, Michalski, C, Hackert, T, Büchler, MW & Neoptolemos, JP 2025, 'Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial', Journal of Clinical Oncology , vol. 43, no. 10, pp. 1240-1253. https://doi.org/10.1200/JCO.24.01118
Daniels, H, Hassan, M, Babiker, O, Rowley, W, Qaisar, A, Phillips, E, Griffin, E, Bell, C, Baraka, B, Acharige, S, Aquino, M, Plant, R, Mencel, J, Chan, S, Parslow, D, Arora, A, Scott-Brown, M, Khakoo, S, Braconi, C, Palmer, D, Ma, YT & Sivakumar, S 2025, 'UK Real-World Evidence of Using Durvalumab Plus Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer via an Early Access Scheme', Cancers, vol. 17, no. 17, 2732. https://doi.org/10.3390/cancers17172732
Rannikko, JH, Verlingue, L, De miguel, M, Pasanen, A, Robbrecht, D, Skytta, T, Iivanainen, S, Shetty, S, Ma, YT, Graham, DM, Arora, SP, Jaakkola, P, Yap, C, Xiang, Y, Mandelin, J, Karvonen, MK, Jalkanen, J, Karaman, S, Koivunen, JP, Minchom, A, Hollmén, M & Bono, P 2023, 'Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial', Cell Reports Medicine, vol. 4, no. 12, 101307. https://doi.org/10.1016/j.xcrm.2023.101307
Ghaneh, P, Palmer, D, Cicconi, S, Jackson, R, Halloran, CM, Rawcliffe, C, Sripadam, R, Mukherjee, S, Soonawalla, Z, Wadsley, J, Al-Mukhtar, A, Dickson, E, Graham, J, Jiao, L, Wasan, HS, Tait, IS, Prachalias, A, Ross, P, Valle, JW, O'Reilly, DA, Al-Sarireh, B, Gwynne, S, Ahmed, I, Connolly, K, Yim, K-L, Cunningham, D, Armstrong, T, Archer, C, Roberts, K, Ma, YT, Springfeld, C, Tjaden, C, Hackert, T, Büchler, MW & Neoptolemos, JP 2023, 'Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial', The Lancet Gastroenterology & Hepatology, vol. 8, no. 2, pp. 157-168. https://doi.org/10.1016/S2468-1253(22)00348-X
Mosconi, C, O’Rourke, J, Kloeckner, R, Sturm, L, Golfieri, R, Celsa, C, Fateen, W, Odisio, BC, Garanzini, EM, Peck-Radosavljevic, M, Borghi, A, Ma, YT, Stoehr, F, Bettinger, D, Giuffrida, P, Aithal, GP, Lin, Y-M, Spreafico, C, Giampalma, E, Johnson, P & Cucchetti, A 2023, 'Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma', Cardiovascular and Interventional Radiology, vol. 46, no. 4, pp. 449-459. https://doi.org/10.1007/s00270-023-03375-4
Review article
Lawson, A, Kamarajah, SK, Parente, A, Pufal, K, Sundareyan, R, Pawlik, TM, Ma, YT, Shah, T, Kharkhanis, S, Dasari, BVM & Sahin, I (ed.) 2023, 'Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis', Cancers, vol. 15, no. 12, 3166. https://doi.org/10.3390/cancers15123166
View all publications in research portal